Singapore Diagnostics
From its establishment in late 2013, Singapore Diagnostics (SGD) has grown to be among the largest laboratories in the Philippines. Processing laboratory tests for over 300 hospitals, clinic labs and healthcare institutions in the Philippines, SGD serves up to 50,000 patients every month. The company is a subsidiary of Pathology Asia (PAH), among Southeast Asia’s large medical diagnostic groups with laboratory, genomic and digital health operations in Singapore, Malaysia, Indonesia, Vietnam and Australia.
See below for the Latest Singapore Diagnostics News, Analysis, Profit Results, Share Price Information, and Commentary.
Singapore Diagnostics Clinches Consecutive Diagnostics Provider of the Year Win, Sweeps Awards in Employee Engagement, Service Innovation
Singapore Diagnostics Clinches Consecutive Diagnostics Provider of the Year Win, Sweeps Awards in Employee Engagement, Service Innovation
It enables quality through its 46 facilities that operate with fully automated equipment, integrated IT, and a seamless logistics network.
Singapore Diagnostics revolutionises Philippine healthcare through quality, accessibility, and talent development
Singapore Diagnostics, the Philippine flagship company of Pathology Asia, has improved access to healthcare services with its 40 locations across the nation.
Singapore Diagnostics wins as Diagnostics Provider of the Year
From a single site in the Philippines, it has since spread to 40 locations in the country.
Most Read
1. Hong Kong seeks prescription for nursing shortage 2. ASEAN medical tourism set to outpace global revenue growth 3. OUE Healthcare subsidiary secures majority stake in Rehab Matters 4. Thomson and Monash University Malaysia partner for joint research 5. Sunway Medical Centre Ipoh to open in Q2 2025Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
